Multiple Sclerosis

Search for publications

Only original articles, editorials, guidelines.

  • Gil-Varea, Elia, Fedetz, Maria, Eixarch, Herena, Spataro, Nino, Villar, Luisa Maria, Urcelay, Elena, Saiz, Albert, Fernandez, Oscar, Leyva, Laura, Ramio-Torrenta, Lluis, Vandenbroeck, Koen, Otaegui, David, Castillo-Trivino, Tamara, Izquierdo, Guillermo, Malhotra, Sunny, Bosch, Elena, Navarro, Arcadi, Alcina, Antonio, Montalban, Xavier, Matesanz, Fuencisla, Comabella, Manuel.

    A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells

    Journal Of Clinical Medicine . 9(3): . Number of citations: 5

    [doi:10.3390/jcm9030625]

  • Martínez-García MÁ, Ojeda-Ojeda, Miriam, Rodriguez-Martin, Eulalia, Insenser, Maria, Moncayo, Samuel, Alvarez-Blasco, Francisco, Luque-Ramirez, Manuel, Escobar-Morreale, Hector F..

    TLR2 and TLR4 Surface and Gene Expression in White Blood Cells after Fasting and Oral Glucose, Lipid and Protein Challenges: Influence of Obesity and Sex Hormones

    Biomolecules . 10(1): . Number of citations: 16

    [doi:10.3390/biom10010111]

  • Mariscal-Rodríguez A, Villar Guimerans LM, López-Trascasa M, Hernández González M, Moga Naranjo E.

    Laboratory guidelines for the diagnosis of patients with cryoglobulinaemic syndrome.

    REVISTA CLINICA ESPANOLA . 219(9): 505-513.

    [doi:10.1016/j.rce.2018.10.006]

  • Muñoz-San Martín M, Reverter G, Robles-Cedeño R, Buxò M, Ortega FJ, Gómez I, Tomàs-Roig J, Celarain N, Villar LM, Perkal H, Fernández-Real JM, Quintana E, Ramió-Torrentà L.

    Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions.

    JOURNAL OF NEUROINFLAMMATION . 16(1): 220-220. Number of citations: 28

    [doi:10.1186/s12974-019-1590-5]

  • Alonso-Canovas A, Tembl Ferrairó JI, Martínez-Torres I, Lopez-Sendon Moreno JL, Parees-Moreno I, Monreal-Laguillo E, Pérez-Torre P, Toledano Delgado R, García Ribas G, Sastre Bataller I, Masjuan J, Martinez-Castrillo JC, Walter U.

    Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.

    PARKINSONISM & RELATED DISORDERS . 68: 40-45. Number of citations: 9

    [doi:10.1016/j.parkreldis.2019.09.032]

  • Moreira A, Alari-Pahissa E, Munteis E, Vera A, Zabalza A, Llop M, Villarrubia N, Costa-García M, Álvarez-Lafuente R, Villar LM, López-Botet M, Martínez-Rodríguez JE.

    Adaptive Features of Natural Killer Cells in Multiple Sclerosis.

    Frontiers in immunology . 10: 2403-2403. Number of citations: 13

    [doi:10.3389/fimmu.2019.02403]

  • Fissolo N, Cervera-Carles L, Villar Guimerans LM, Lleó A, Clarimón J, Drulovic J, Dujmovic I, Voortman M, Khalil M, Gil E, Navarro L, Álvarez-Cermeño JC, Montalban X, Comabella M.

    Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis.

    MULTIPLE SCLEROSIS JOURNAL . 25(11): 1535-1538. Number of citations: 3

    [doi:10.1177/1352458518786055]

  • Fraussen J, Marquez S, Takata K, Beckers L, Montes Diaz G, Zografou C, Van Wijmeersch B, Villar LM, O'Connor KC, Kleinstein SH, Somers V.

    Phenotypic and Ig Repertoire Analyses Indicate a Common Origin of IgD - CD27 - Double Negative B Cells in Healthy Individuals and Multiple Sclerosis Patients.

    JOURNAL OF IMMUNOLOGY . 203(6): 1650-1664. Number of citations: 16

    [doi:10.4049/jimmunol.1801236]

  • Cuello JP, Martínez Ginés ML, Kuhle J, García Domínguez JM, Lozano Ros A, Romero Delgado F, Higueras Y, Meldaña Rivera A, Goicochea Briceño H, García-Tizon Larroca S, de-León Ruiz J, Michalak Z, Barro C, Álvarez Lafuente R, Medina Heras S, Fernández Velasco JI, Tejeda-Velarde A, Domínguez-Mozo MI, Muriel A, de Andrés C, Villar LM.

    Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study.

    EUROPEAN JOURNAL OF NEUROLOGY . 26(9): 1200-1204. Number of citations: 11

    [doi:10.1111/ene.13965]

  • Mestre L, Carrillo-Salinas FJ, Mecha M, Feliú A, Espejo C, Álvarez-Cermeño JC, Villar LM, Guaza C.

    Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.

    Frontiers in immunology . 10: 1374-1374. Number of citations: 23

    [doi:10.3389/fimmu.2019.01374]

  • Fernandez O, Tintore M, Saiz A, Calles-Hernandez MC, Comabella M, Ramio-Torrenta L, Oterino A, Izquierdo G, Tellez N, Garcia-Merino JA, Brieva L, Arnal-Garcia C, Aladro Y, Mendibe-Bilbao MM, Meca-Lallana JE, Romero-Pinel L, Martinez-Gines ML, Arroyo R, Oreja-Guevara C, Costa-Frossard L, Carrascal P, Rodriguez-Antiguedad A.

    Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (II).

    REVISTA DE NEUROLOGIA . 68(11): 468-479.

    [doi:10.33588/rn.6811.2019121]

  • van Rossum JA, Killestein J, Villar LM, Riskind PN, Freedman MS, Teunissen C.

    gMS-Classifier1 does not predict disability progression in multiple sclerosis.

    MULTIPLE SCLEROSIS JOURNAL . 25(7): 1010-1011.

    [doi:10.1177/1352458518798048]

  • Pérez-Miralles F, Prefasi D, García-Merino A, Ara JR, Izquierdo G, Meca-Lallana V, Gascón F, Martínez-Ginés ML, Ramió-Torrentà L, Costa-Frossard L, Fernández Ó, Moreno-García S, Maurino J, Casanova-Estruch B.

    Perception of stigma in patients with primary progressive multiple sclerosis.

    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL . 5(2): . Number of citations: 5

    [doi:10.1177/2055217319852717]

  • Sainz de la Maza S, Medina S, Villarrubia N, Costa-Frossard L, Monreal E, Tejeda-Velarde A, Rodríguez-Martín E, Roldán E, Álvarez-Cermeño JC, Villar LM.

    Factors associated with dimethyl fumarate-induced lymphopenia.

    JOURNAL OF THE NEUROLOGICAL SCIENCES . 398: 4-8. Number of citations: 19

    [doi:10.1016/j.jns.2019.01.007]

  • Medina S, Sainz de la Maza S, Villarrubia N, Álvarez-Lafuente R, Costa-Frossard L, Arroyo R, Monreal E, Tejeda-Velarde A, Rodríguez-Martín E, Roldán E, Álvarez-Cermeño JC, Villar LM.

    Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients.

    Annals of Clinical and Translational Neurology . 6(2): 355-363. Number of citations: 10

    [doi:10.1002/acn3.711]

  • Tejeda Velarde, Amalia, Medina Heras, Silvia, Villar Guimerans, Luisa Maria.

    Biomarkers for Multiple Sclerosis

    RSC Drug Discovery Series . 70: 55-75.

    [doi:10.1039/9781788016070]

  • Villarrubia N, Rodríguez-Martín E, Alari-Pahissa E, Aragón L, Castillo-Triviño T, Eixarch H, Ferrer JM, Martínez-Rodríguez JE, Massot M, Pinto-Medel MJ, Prada Á, Rodríguez-Acevedo B, Urbaneja P, Gascón-Gimenez F, Herrera G, Hernández-Clares R, Salgado MG, Oterino A, Segundo DS, Cuello JP, Gil-Herrera J, Cámara C, Gómez-Gutiérrez M, Martínez-Hernández E, Meca-Lallana V, Moga E, Muñoz-Calleja C, Querol L, Presas-Rodríguez S, Teniente-Serra A, Vlagea A, Muriel A, Roldán E, Villar LM.

    Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.

    CLINICA CHIMICA ACTA . 488: 135-142. Number of citations: 1

    [doi:10.1016/j.cca.2018.11.008]

  • Malhotra S, Villar LM, Costa C, Midaglia L, Cubedo M, Medina S, Fissolo N, Río J, Castilló J, Álvarez-Cermeño JC, Sánchez A, Montalban X, Comabella M.

    Circulating EZH2-positive T cells are decreased in multiple sclerosis patients.

    JOURNAL OF NEUROINFLAMMATION . 15(1): 296-296. Number of citations: 5

    [doi:10.1186/s12974-018-1336-9]